论文部分内容阅读
比较ＡＣＥ－抑制剂和其他抗高血压药对血透病人左心功能及心肌重量的影响。方法：血透病人被分为３组，比较治疗１２个月后血压、左心功能及左心肥大的改变。结果：组１（ＡＣＥ－抑制剂）在治疗４－５周后血压有明显降低，心脏检查示：治疗后，组１ＬＶＥＤＤ、ＬＶＭ、ＬＶＭＩ、ＩＶＳＤ、ＬＶＰＷＤ和Ｅ均有明显降低，Ａ和Ｅ／Ａ有明显升高，ＬＶＭＩ的改变与透析开始及透析结束时的平均动脉压呈明显正相关，在组２及对照组则无显著性改变。结论：在长期维持性透析病人，ＡＣＥ－抑制剂对改善心功能和减轻左心肥大有明显疗效
To compare the effects of ACE-inhibitors and other antihypertensives on left ventricular function and myocardial weight in patients with hemodialysis. Methods: Hemodialysis patients were divided into three groups, comparing the changes of blood pressure, left ventricular function and left ventricular hypertrophy after 12 months of treatment. Results: The blood pressure of group 1 (ACE-inhibitor) decreased significantly after 4-5 weeks of treatment. The results of cardiac examination showed that the levels of LVEDD, LVM, LVMI, IVSD, LVPWD and E were significantly decreased A was significantly increased, LVMI changes and mean dialysis began dialysis and mean arterial pressure was positively correlated in group 2 and the control group no significant change. CONCLUSIONS: ACE-inhibitors have a significant effect on improving cardiac function and reducing left ventricular hypertrophy in long-term maintenance dialysis patients